[2'-OMe-G(iBu)](pCyEt)[2'-OMe-G(iBu)-3'-CE-Phosphoramidite]](http://shop.hongene.com/cdn/shop/files/OP-233_V1_9fea1439-649c-4b7e-96d7-b9e642d9f4f3.jpg?v=1755668329&width=600)
[5'-O-DMTr-2'-OMe-U](pCyEt)[2'-OMe-G(iBu)](pCyEt)[2'-OMe-G(iBu)-3'-CE-Phosphoramidite]
| Catalog No. | OP-233 |
| Purity | UPLC≥95% |
| Molecular Formula | C76H95N16O25P3 |
| Molecular Weight | 1725.60 |
| Storage Condition | -20±5℃ |
[5'-O-DMTr-2'-OMe-U](pCyEt)[2'-OMe-G(iBu)](pCyEt)[2'-OMe-G(iBu)-3'-CE-Phosphoramidite]
[5'-O-DMTr-2'-OMe-U](pCyEt)[2'-OMe-G(iBu)](pCyEt)[2'-OMe-G(iBu)-3'-CE-Phosphoramidite] - N (Normal) is backordered and will ship as soon as it is back in stock.
Couldn't load pickup availability
Shipping notes
Shipping notes
Related Products
Specifications
Specifications
-
Catalog No.OP-233
-
SMILESO=P(OCCC#N)(OC[C@H]1O[C@@H](N2C(N=C(NC(C(C)C)=O)NC3=O)=C3N=C2)[C@H](OC)[C@@H]1OP(OCCC#N)(OC[C@H]4O[C@@H](N(C=N5)C6=C5C(NC(NC(C(C)C)=O)=N6)=O)[C@H](OC)[C@@H]4OP(OCCC#N)N(C(C)C)C(C)C)=O)O[C@H]7[C@@H](OC)[C@H](N8C(NC(C=C8)=O)=O)O[C@@H]7COC(C9=CC=CC=C9)(C%10=CC=C(OC)C=C%10)C%11=CC=C(OC)C=C%11
-
Molecular FormulaC76H95N16O25P3
-
Molecular Weight1725.60
-
PurityUPLC≥95%
-
Storage Condition-20±5℃
Documentation
Documentation
-
Catalog No.OP-233
-
SMILESO=P(OCCC#N)(OC[C@H]1O[C@@H](N2C(N=C(NC(C(C)C)=O)NC3=O)=C3N=C2)[C@H](OC)[C@@H]1OP(OCCC#N)(OC[C@H]4O[C@@H](N(C=N5)C6=C5C(NC(NC(C(C)C)=O)=N6)=O)[C@H](OC)[C@@H]4OP(OCCC#N)N(C(C)C)C(C)C)=O)O[C@H]7[C@@H](OC)[C@H](N8C(NC(C=C8)=O)=O)O[C@@H]7COC(C9=CC=CC=C9)(C%10=CC=C(OC)C=C%10)C%11=CC=C(OC)C=C%11
-
Molecular FormulaC76H95N16O25P3
-
Molecular Weight1725.60
-
PurityUPLC≥95%
-
Storage Condition-20±5℃
Why choose Hongene?
Trusted Partner in Nucleic Acid
Integrated Supply & Commercial Scale
With 26+ years of expertise, we control a secure supply chain for RNA raw materials and provide reliable GMP-grade oligo synthesis from research to commercial kilogram-scale production.
Proprietary Technology & IP
Our proprietary Chemoenzymatic Ligation Platform combines chemical andenzymatic methods, enabling high-putity, cost-effective, and large-scale production of RNA-based therapeutics.
Rigorous Quality
We implement multiple stringent QC steps, maintain ISO certifications, and ensure >99% batch-to-batch consistency, reducing scale-up and PPQ risks.
Manufacturing Scalability
Hongene operates 1.67 million sq. ft Oligonucleotide Manufacturing Facility, with advanced equipments including multiple OligoPilot™ and OligoProcess™ synthesizers (10-1800 mmol). 48 flexible production lines enable one-stop seamless scaling-up of API production from gram-level to tons and acheive high purity of 98%, meeting NMPA, FDA, and EMA standards.
Global Business Network
Our products and services reach over 40 countries and regions, supporting around 3,000 clients worldwide.
